Dracaena cinnabari

Dragon blood resin from Dracaena cinnabari contains active compounds including dracorhodin, flavonoids, and tannins that contribute to its wound-healing properties. Dracorhodin appears to promote tissue regeneration and accelerate wound closure. The tannins provide astringent effects that help contract wound edges, while flavonoids contribute anti-inflammatory and antioxidant activity. The resin forms a protective barrier over wounds, preventing microbial colonization. Evidence level: C (preliminary studies and traditional use support these mechanisms, though clinical trials are limited).

There are no well-documented drug interactions for Dracaena cinnabari resin in scientific literature. However, due to limited clinical research, potential interactions cannot be ruled out. The anti-inflammatory and antimicrobial properties may theoretically complement or interfere with similar pharmaceutical agents. Patients taking anticoagulants, antiplatelet medications, or immunosuppressants should exercise caution and consult a healthcare provider before using dragon blood resin products. Evidence level: C (insufficient data to confirm safety with specific medications).

For topical use, Dracaena cinnabari resin is applied directly to wounds or affected areas as needed. Traditional applications involve applying a thin layer of resin or using it in poultice form. There is no standardized oral dosage established, and internal use is not well-studied. Users should follow product-specific instructions if using commercial preparations. Given limited clinical evidence, starting with minimal amounts to assess skin tolerance is advisable. Evidence level: C (traditional use guidelines, no established clinical dosing standards).

Dragon blood resin from Dracaena cinnabari is considered unsafe during pregnancy and should be avoided. There is insufficient safety data regarding use in pregnant or breastfeeding women. Traditional use has not established a safety profile for this population, and some compounds in the resin may stimulate uterine contractions or affect fetal development. Women who are pregnant, planning pregnancy, or breastfeeding should not use this herb without explicit medical guidance. Evidence level: C (traditional contraindication, lack of safety studies).

The resin from Dracaena cinnabari, commonly called dragon's blood, has been used traditionally on Socotra Island for wound healing, as an antimicrobial agent, and for inflammatory conditions. Folk medicine applications include treating skin lesions, burns, and infections. The bright red resin has also been used historically as a varnish and dye. Modern research has identified antimicrobial and anti-inflammatory properties supporting some traditional uses, though clinical evidence remains limited. Evidence level: C (ethnobotanical documentation with preliminary pharmacological support).